Log in
Enquire now
‌

US Patent 8129152 Method of producing enantioselective immobilized candida rugosa lipase

Patent 8129152 was granted and assigned to Putra Malaysia University on March, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
‌
Putra Malaysia University
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8129152
Patent Inventor Names
Siti Salhah Othman0
Mohd. Basyaruddin Abd. Rahman0
Mohd. Zobir Hussein0
Raja Noor Zaliha Abd. Rahman0
Abu Bakar Salleh0
Halila Jasmani0
Mahiran Basri0
Date of Patent
March 6, 2012
Patent Application Number
12222104
Date Filed
August 1, 2008
Patent Primary Examiner
‌
David Naff
Patent abstract

Immobilization of Candida rugosa lipase on a carrier selected from the group consisting of macroporous adsorbent resin of the acrylic type, synthetic epoxy activated resin and Mg—Al-hydrotalcite enhances its enantioselectivity by six to seven folds. The immobilized Candida rugosa lipase is suitable for use in resolution of racemic alcohols and/or carboxylic acids, particularly in resolution of racemic menthol or production of menthyl esters.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8129152 Method of producing enantioselective immobilized candida rugosa lipase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.